Bioentrepreneurship in Medical Biotechnology

Author(s):  
Neeti Sharma

Being a developing sector, biotechnology combines both medical science and various facets of a sustainable environment. Scientific innovations from academics and industry contribute towards the rise of bioentrepreneurship across the world. Medical biotechnology helps the treatment and prevention of human diseases by using living cells and cell materials to research and produce pharmaceutical and diagnostic products. It requires incubation of research, product, and its yield for the improvement of humans to transform medical research into an entrepreneurial industry. Biotechnology provides an opportunity for entrepreneurs to harness the power of genomics for the development and marketing of new therapeutics. These opportunities allow entrepreneurs to visualize the creation of both disruptive business and disruptive technologies for today's business models. This chapter will summarize multiple features of entrepreneurship in the biotechnology industry in combination with other industries and will explain the significance of bio-entrepreneurship in the field of medical biotechnology.

2020 ◽  
Vol 17 (4) ◽  
pp. 548-552 ◽  
Author(s):  
Badri Shrestha ◽  
Louese Dunn

The pinnacle of success achieved by the medical science and the benefits accrued to the patients have become possible through the medical research where human participants in the research are exposed to hazards inherent to the experiments. To protect the human subjects and to maintain high ethical standards, the World Medical Association has adopted “The Declaration of Helsinki” in 1964. After two years of consultation with the experts throughout the world, the seventh revision of the Declaration was adopted on 19th October 2013 in Brazil. The aim of this article is to review the seventh revision of the Declaration of Helsinki in relation to medical research involving human subjects and highlight the amendments made in the latest revision which are relevant to clinical research in human subjects. The latest revision has made four substantial changes on the existing Declaration, whch include dealing with the compensation of the trial-related injuries, approval of use of placebos in the clinical trials, protection of vulnerable groups and the post-trial provisions. The implications of these amendments in the clinical research are highlighted.Keywords: Consent; Declaration of Helsinki; ethics; experimental medicine; research; seventh revision.


Sir Henry Dale was a student in the late Victorian years when the practice of medicine was beginning to change from an art to a science. He became an acknowledged leader in medical science; he studied the action of drugs, the body’s defensive systems against disease, the balance of glandular activity and especially the chemical links between nerve and muscle. His discoveries in the field of chemical transmission in the nervous system won him the Nobel Prize for Medicine jointly with Otto Loewi in 1938, and his laboratory on Hampstead Heath attracted some of the ablest young scientists from every part of the world. He was a leader in scientific planning as well as a great investigator. Between the two wars the National Institute for Medical Research was under his care and he had countless committees to manage, and from 1940 to 1945 he was President of the Royal Society with the war to be fought and weighty decisions of scientific policy to be faced: and for twenty years after, he remained the elder statesman to whom all of us turned for advice


2003 ◽  
Vol 9 (2) ◽  
pp. 8-16
Author(s):  
John Jackson

ABSTRACTWe pick up the case as the new venture moves from a decade of dedicated scientific research into the early stages of becoming a commercially viable business. The case considers the potential of the Near Infra Red (NIR) spectroscopy technology to revolutionise the fruit markets of the world as well as the realities of trying to change existing practices and culture. The dilemma of first-mover advantage as compared to learning from the mistakes of early competitors is included. Various possible business models are introduced. The case also asks the students to consider some of the key issues of a new product/service launch.


Author(s):  
Dr. Sandip Tawade

Ayurveda is not only an ancient medical science but it is a complete life science.The main aim of Ayurveda is to maintain the health of a healthy person & to cure the disease of diseased person. From last few decades due to globalisation there is drastic change in working pattern, dietary habits & lifestyle. According to a new research, lifestyle diseases replaced traditional health risk factors resulting in an increase in incidents of diseases & deaths in India in the last two decades. Now most of the diseases & deaths are caused by High Blood Pressure, high cholesterol, obesity, alcohol use and poor diet. Unhealthy lifestyle is the root cause of many diseases broadly termed as lifestyle disorder. Hypertension is the most common lifestyle disease affecting population all over the world. About 26.4% of the world adult population in 2020 had hypertension and 29.2% were projected to have this condition by 2025. India is labeled as global capital of hypertension. The Ayurveda concentrates on achieving the promotion of health, prevention and management of disease for a healthy and happy life in the ailing society. The principals of Ayurveda are focused on maintaining good health by good diet and good lifestyle. Proper dietary habits, proper exercise, Yoga, Meditation along with Ayurveda herbs can be beneficial to balancing of mind, which reduce stress and maintain the blood pressure. The present review article is aimed that the planning of proper herbal medications as per Ayurveda guidelines will definitely control the high blood pressure without any hazardous side effects of drugs.


2021 ◽  
Author(s):  
Hanan Al-Khalaifah ◽  
Mohammad Al-Otaibi ◽  
Abdulaziz Al-Ateeqi

With the onset of the coronavirus pandemic in December 2019 in China, and the alarming rate at which it has spread across the world has unleashed not only fear, but has taken a toll on social, economic, health, and governing capabilities of the various countries infected with the virus. The pandemic is affecting all aspects of life, including industries such as the animal production industry all over the world. This includes plant, livestock and poultry production. Food security is accordingly impacted, as these industries are vital elements that are contributing to securing food to populations worldwide. In this review, light is shed on the origin of coronaviruses with special emphasis on COVID-19. It also includes introduction of symptoms, epidemiology and pathogenesis, etiology, and prevention. As the disease progresses, scientists are working around the clock in the hope of an effective vaccine, and they managed to introduce some to the worldwide populations. The world faces challenges on a day-to-day basis until most people are vaccinated.


Author(s):  
Dimple . ◽  
Ashwani Kumar ◽  
Vikas Kumar ◽  
Vidisha Tomer

Diabetes mellitus (DM) is a chronic disease which has clinched the world. More than 300 million people of the world are suffering from this disease and the number is still increasing at a rapid rate as modern medical science has no permanent solution for the disease. Current scenario of the nutraceuticals has increased patient’s faith on the traditional medicinal system and world nutraceutical industry is estimated to reach $285.0 billion by 2021. The increasing trend of nutraceuticals in diabetes treatment makes it important to collect the traditional knowledge of medicines under one heading as it can help researchers to formulate new functional foods and nutraceuticals which can either lower down the risk or cure DM. In addition, the discussion of market available food products, their active components and possible health benefits can help the patients to understand the herbal medicines in a better way.


Author(s):  
Ifeoluwa Garba ◽  
Richard Bellingham

Access to energy is crucial in tackling many of the current global development challenges that impact on people’s economic, health and social well-being as well as the ability to meet the commitments of reducing carbon emissions through clean energy use. Despite increased attention from multiple governments and agencies, energy poverty remains a serious sustainable development issue in many developing countries. To date, most research have focused on general access to electricity and the generation of clean energy to replace fossil fuels, failing to address the lack of basic access to clean energy for cooking and heating. More people in the world lack access to clean cooking fuels than to electricity. This issue is one aspect of a broader research which investigates the impacts of optimized energy policy and energy business models on sustainable development in developing countries.


2018 ◽  
Vol 61 (2) ◽  
pp. 59-83 ◽  
Author(s):  
Massimo Garbuio ◽  
Nidthida Lin

The future of health care may change dramatically as entrepreneurs offer solutions that change how we prevent, diagnose, and cure health conditions, using artificial intelligence (AI). This article provides a timely and critical analysis of AI-driven health care startups and identifies emerging business model archetypes that entrepreneurs from around the world are using to bring AI solutions to the marketplace. It identifies areas of value creation for the application of AI in health care and proposes an approach to designing business models for AI health care startups.


Sign in / Sign up

Export Citation Format

Share Document